07:00 , Aug 19, 2013 |  BioCentury  |  Emerging Company Profile

SynapDx: Autism early warning

SynapDx Corp. aims to use RNA sequencing to lower the age of diagnosis for autism spectrum disorder into early toddlerhood, which would improve the odds of success for behavioral therapy. The company has raised more than...
07:00 , May 13, 2013 |  BC Week In Review  |  Clinical News

Blood-based autism test: Clinical trial started

SynapDx Corp., Southborough, Mass.   Product: Blood-based autism test ( SDX-002)   Business: Diagnostic   Molecular target: NA   Description: Blood-based RNA gene expression profiling test   Indication: Identify autism spectrum disorder (ASD)   Endpoint: RNA gene expression in peripheral...